Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
ShangBay Capital is a venture capital firm located in Palo Alto, California, founded in 2015. The firm manages a portfolio of over 75 companies, focusing on medical devices, biotechnology, and healthcare technology. They aim to address significant unmet clinical needs through innovative solutions.
ShangBay Capital invests in early-stage opportunities within medical devices, biopharma, and healthcare that demonstrate clinical benefits for unmet needs. The firm collaborates closely with entrepreneurs to support product commercialization and startup growth, leveraging its understanding of market dynamics in the medical device industry.
Notable exits from ShangBay Capital's portfolio include Ceribell, Lucira Health (NASDAQ: LHDX), Arrinex (acquired by Stryker), Apexigen (NASDAQ: APGN), Berkeley Lights (NASDAQ: BLI), and DeVoro Medical (acquired by Boston Scientific).
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.